Ancient herb may tame inflammation after heart attack

NCT ID NCT07445581

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether Tanhuo decoction, a traditional herbal mixture, can reduce inflammation and prevent future heart or brain events in elderly patients who have had both a heart attack and hardened brain arteries. About 480 participants will take either the herbal drink or a placebo for one week, alongside standard heart medications. Researchers will track blood markers, heart function, and major events like strokes or heart attacks for up to a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Tanhuo decoction (herbal mixture)

What this could lead to

If it works, this could point toward a natural supplement to reduce inflammation and lower the risk of heart attacks or strokes in elderly patients.

What could go wrong

This is an early-stage trial with no phase, so results are uncertain. The herbal treatment is given for only 7 days, and long-term benefits are unknown. Side effects are not yet well-documented.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME COMORBID WITH CEREBRAL ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome cerebral atherosclerosis intracranial arteriosclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Xuanwu Hospital of Capital Medical University

    Beijing, Beijing Municipality, 100032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••